MA
58
-11
ALLE
35
-6
QCOM
48
-14
MU
48
-4
TROW
34
7
ITW
31
-2
VRSN
53
-4
ADI
47
-4
ES
28
4
PFE
35
-2
BLK
61
-5
HSIC
51
-2
BA
39
-5
GILD
69
-2
NKE
18
-3
NWS
64
-5
URI
42
-3
HES
68
-2
IRM
38
-3
SWKS
37
5
MA
58
-11
ALLE
35
-6
QCOM
48
-14
MU
48
-4
TROW
34
7
ITW
31
-2
VRSN
53
-4
ADI
47
-4
ES
28
4
PFE
35
-2
BLK
61
-5
HSIC
51
-2
BA
39
-5
GILD
69
-2
NKE
18
-3
NWS
64
-5
URI
42
-3
HES
68
-2
IRM
38
-3
SWKS
37
5
Financhill
Back

H.B. Fuller 10K Form

Sell
32

FUL
H.B. Fuller

Last Price:
$54.77
Seasonality Move:
5.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FUL News And Ratings

See the #1 stock for the next 7 days that we like better than FUL

FUL Financial Statistics

Sales & Book Value

Annual Sales: $3.6B
Cash Flow: $-85.9M
Price / Cash Flow: 42.24
Annual Sales: $32.80
Price / Book: 1.67

Profitability

EPS (TTM): 2.00000
Net Income (TTM): $112.5M
Gross Margin: $1.1B
Return on Equity: 6.24%
Return on Assets: 2.3%

H.B. Fuller Earnings Forecast

Key H.B. Fuller Financial Ratios

  • The Gross Profit Margin over the past 41 years for FUL is 29.75%.
  • The Selling, General & Administrative Expenses for FUL have been equal to 18.16% of Gross Profit Margin.
  • The Research & Development expenses have been 1.39% of Revenue.
  • The Interest Expense is 102.20% of Operating Income.
  • The Net Earning history of FUL is 3.65% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 21 years.

H.B. Fuller Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Chemicals
Sector: Materials
Current Symbol: FUL
CUSIP: 359694
Website: hbfuller.com

Debt

Debt-to-Equity Ratio: 1.23
Current Ratio: 1.97
Quick Ratio: 1.03

Price-to-Earnings

Trailing P/E Ratio: 23.81
Forward P/E Ratio: 11.92

FUL Technical Analysis vs Fundamental Analysis

Sell
32
H.B. Fuller (FUL) is a Sell

Is H.B. Fuller a Buy or a Sell?

  • H.B. Fuller stock is rated a Sell
    The current H.B. Fuller [FUL] share price is $54.77. The Score for FUL is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.